Papers
11
Total Citations
619
H-Index
7
About
Bin Li is a pioneering thoracic surgeon and clinical researcher whose work sits at the forefront of robotic and minimally invasive esophageal surgery. Based at Shanghai Chest Hospital, one of China's highest-volume esophageal cancer centers, Li has dedicated his career to advancing surgical techniques for esophageal squamous cell carcinoma — a cancer that carries a disproportionately heavy burden in China. His most celebrated contribution, a landmark randomized controlled trial comparing robot-assisted minimally invasive esophagectomy (RAMIE) with conventional approaches, has accumulated nearly 200 citations and provided the field with its most rigorous comparative evidence to date. His 2020 demonstration of 5G-enabled ultra-remote robotic surgery captured international attention with 247 citations, signaling a bold vision for the future of surgical care delivery. Li has also shaped global practice through an international consensus statement on RAMIE and led the multicenter RAMIE and REVATE trials, establishing methodological standards for the field. His investigations into recurrent laryngeal nerve injury, thoracic duct resection, and recurrence patterns reflect a commitment to refining every dimension of patient outcomes, making him an authoritative and innovative voice in minimally invasive oncologic surgery.
Research Focus
Key Achievements
Top Papers
- 15G ultra-remote robot-assisted laparoscopic surgery in China247 citations · 2020
- 2
- 3
- 4
- 5
- 6
- 7
- 8
- 9
- 10